Active ingredientRiociguatCat. No. P-R064-001CAS 625115-55-1Family · Pharmaceutical analytical standards
Riociguat
A stimulator of soluble guanylate cyclase (sGC), the receptor for nitric oxide, and the first of a new class: approved in 2013 for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (CTEPH). This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It was the first medicine approved for CTEPH: until then the only treatment for this disease was surgery, which not every patient can undergo.
Go to the active ingredient →Active ingredientRiociguatCat. No. P-R064-001CAS 625115-55-1
Pharmacopoeial impurityRiociguat EP Impurity ACat. No. P-R064-002CAS 625115-52-8
Pharmacopoeial impurityRiociguat EP Impurity CCat. No. P-R064-003CAS 2920299-23-4
Pharmacopoeial impurityRiociguat EP Impurity DCat. No. P-R064-004CAS 625115-54-0
MetaboliteRiociguat M1 GlucuronideCat. No. P-R064-005CAS 2298383-28-3
MetaboliteRiociguat Metabolite 1Cat. No. P-R064-006CAS 2298383-24-9
Isotopically labelledRiociguat EP Impurity A-d4Cat. No. P-R064-007
Isotopically labelledRiociguat-13C-d3Cat. No. P-R064-009CAS 2749393-44-8
NitrosamineN-Nitroso Riociguat EP Impurity ACat. No. P-R064-010
NitrosamineN-Nitroso Riociguat EP Impurity CCat. No. P-R064-011
NitrosamineN-Nitroso Riociguat Metabolite 1Cat. No. P-R064-012
NitrosamineN-Nitroso Riociguat Impurity 19Cat. No. P-R064-013![Methyl 1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidate](https://img.vitasanlabs.com/vsl-struct/P-R064-014.svg?v=41e934f030)
ImpurityMethyl 1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidateCat. No. P-R064-014CAS 304874-06-4
Pharmacopoeial impurityRiociguat EP Impurity BCat. No. P-R064-016CAS 3052969-92-0
ImpurityRiociguat Impurity 4Cat. No. P-R064-018CAS 1361569-10-9
ImpurityRiociguat Impurity 5Cat. No. P-R064-019CAS 1361569-18-7
ImpurityRiociguat Impurity 5 Lithium SaltCat. No. P-R064-020
ImpurityRiociguat Impurity 6Cat. No. P-R064-021CAS 1361569-23-4
ImpurityRiociguat Impurity 7Cat. No. P-R064-022
ImpurityRiociguat Impurity 8Cat. No. P-R064-023
ImpurityRiociguat Impurity 9Cat. No. P-R064-024
ImpurityRiociguat Impurity 10Cat. No. P-R064-025
ImpurityRiociguat Impurity 11Cat. No. P-R064-026
ImpurityRiociguat Impurity 12Cat. No. P-R064-027
ImpurityRiociguat Impurity 13Cat. No. P-R064-028CAS 428854-24-4
ImpurityRiociguat Impurity 14Cat. No. P-R064-030
ImpurityRiociguat Impurity 15Cat. No. P-R064-031CAS 1361570-27-5
ImpurityRiociguat Impurity 16Cat. No. P-R064-033
ImpurityRiociguat Impurity 17Cat. No. P-R064-034
ImpurityRiociguat Impurity 18Cat. No. P-R064-035
ImpurityRiociguat Impurity 19Cat. No. P-R064-036CAS 1702271-98-4
ImpurityRiociguat Impurity 20Cat. No. P-R064-037CAS 2518331-19-4
ImpurityRiociguat Impurity 21Cat. No. P-R064-038
ImpurityRiociguat Impurity 22Cat. No. P-R064-039No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceRiociguat CRSEDQM code Y0002238Family RiociguatNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.